CONCLUSIONS: The risk of drug-induced rhabdomyolysis due to the potential interaction between lovastatin and azithromycin or clarithromycin should be considered before the concomitant use of these agents.
rhabdomyolysis
lovastatin
rhabdomyolysis
clarithromycin
rhabdomyolysis
azithromycin